Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Gros

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Alimentary Pharmacology & Therapeutics|June 16, 2025
Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, ScotlandAlexander T Elford, Nathan Constantine-Cooke, Phil W Jenkinson, et al.
Gastroenterologia Y Hepatologia|December 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel DiseaseMariam Aguas Peris, Javier Del Hoyo Francisco, Pilar Nos Mateu, et al.
International Journal of Molecular Sciences|May 27, 2023
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF DrugsRosario Medina-Medina, Eva Iglesias-Flores, Jose M Benítez, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Revista Espanola De Enfermedades Digestivas|September 29, 2025
Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remissionBeatriz Gros, Noemí Manceñido, José Manuel Benítez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2024
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort studyPatricia Sanz Segura, Fernando Gomollón, Diego Casas, et al.
Inflammatory Bowel Diseases|March 22, 2024
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCUIria Bastón-Rey, Iago Rodríguez-Lago, Ana María Luque, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH studyMaría José Casanova, Óscar Nantes, Pilar Varela, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Alimentary Pharmacology & Therapeutics|June 16, 2025
Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, ScotlandAlexander T Elford, Nathan Constantine-Cooke, Phil W Jenkinson, et al.
Gastroenterologia Y Hepatologia|December 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel DiseaseMariam Aguas Peris, Javier Del Hoyo Francisco, Pilar Nos Mateu, et al.
International Journal of Molecular Sciences|May 27, 2023
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF DrugsRosario Medina-Medina, Eva Iglesias-Flores, Jose M Benítez, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Revista Espanola De Enfermedades Digestivas|September 29, 2025
Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remissionBeatriz Gros, Noemí Manceñido, José Manuel Benítez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2024
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort studyPatricia Sanz Segura, Fernando Gomollón, Diego Casas, et al.
Inflammatory Bowel Diseases|March 22, 2024
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCUIria Bastón-Rey, Iago Rodríguez-Lago, Ana María Luque, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH studyMaría José Casanova, Óscar Nantes, Pilar Varela, et al.
Pageof 4